form_ex23-375.htm

0001329067-11-000012.txt : 20111230 0001329067-11-000012.hdr.sgml : 20111230 20111230130955 ACCESSION NUMBER: 0001329067-11-000012 CONFORMED SUBMISSION TYPE: NSAR-B PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20111031 FILED AS OF DATE: 20111230 DATE AS OF CHANGE: 20111230 EFFECTIVENESS DATE: 20111230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER SERIES FUND INC CENTRAL INDEX KEY: 0000356865 IRS NUMBER: 061207374 STATE OF INCORPORATION: MD FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NSAR-B SEC ACT: 1940 Act SEC FILE NUMBER: 811-03346 FILM NUMBER: 111288674 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: CONNECTICUT MUTUAL INVESTMENT ACCOUNTS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CONNECTICUT MUTUAL LIQUID ACCOUNT INC DATE OF NAME CHANGE: 19851106

0000356865 S000007308 Oppenheimer Disciplined Allocation Fund

C000020076 A

C000020077 B

C000020078 C

C000020079 N

0000356865 S000007309 Oppenheimer Value Fund

C000020080 A

C000020081 B

C000020082 C

C000020083 N

C000033091 Y

C000110989 I

NSAR-B 1 answer.fil OPPENHEIMER VALUE FUND PAGE 1 000 B000000 10/31/2011 000 C000000 356865 000 D000000 N 000 E000000 NF 000 F000000 Y 000 G000000 N 000 H000000 N 000 I000000 6.1 000 J000000 A 001 A000000 OPPENHEIMER SERIES FUND, INC. 001 B000000 811-3346 001 C000000 3037683468 002 A000000 6803 S. Tucson Way 002 B000000 Centennial 002 C000000 CO 002 D010000 80112 002 D020000 3924 003 000000 N 004 000000 N 005 000000 N 006 000000 N 007 A000000 Y 007 B000000 1 007 C010500 5 007 C020500 Oppenheimer Value Fund 007 C030500 N 008 A00AA01 OPPENHEIMERFUNDS, INC. 008 B00AA01 A 008 C00AA01 801-08253 008 D01AA01 NEW YORK 008 D02AA01 NY 008 D03AA01 10281 008 D04AA01 1008 011 A00AA01 OPPENHEIMERFUNDS DISTRIBUTOR, INC 011 B00AA01 8-22992 011 C01AA01 NEW YORK 011 C02AA01 NY 011 C03AA01 10281 011 C04AA01 1008 012 A00AA01 OPPENHEIMERFUNDS, INC. 012 B00AA01 84-01562 012 C01AA01 CENTENNIAL 012 C02AA01 CO 012 C03AA01 80112 012 C04AA01 3924 013 A00AA01 KPMG LLP 013 B01AA01 DENVER 013 B02AA01 CO 013 B03AA01 80202 015 A00AA01 BROWN BROTHERS HARRIMAN 015 B00AA01 C PAGE 2 015 C01AA01 BOSTON 015 C02AA01 MA 015 C03AA01 02109 015 E01AA01 X 018 00AA00 Y 019 A00AA00 Y 019 B00AA00 95 019 C00AA00 OPPENHEIMR 020 A000001 Barclay's Capital 020 B000001 06-1031656 020 C000001 197 020 A000002 GOLDMAN, SACHS & CO. 020 B000002 13-5108880 020 C000002 182 020 A000003 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 020 B000003 13-5674085 020 C000003 156 020 A000004 CREDIT SUISSE SECURITIES (USA) LLC 020 B000004 13-8988118 020 C000004 117 020 A000005 BNY CONVERGEX EXECUTION SOLUTIONS LLC 020 B000005 13-3989198 020 C000005 93 020 A000006 BGC FINANCIAL, LP 020 C000006 85 020 A000007 CITIGROUP GLOBAL MARKETS INC. 020 B000007 11-2418191 020 C000007 74 020 A000008 UBS SECURITIES LLC 020 B000008 98-0186363 020 C000008 71 020 A000009 LIQUIDNET, INC. 020 B000009 13-4095933 020 C000009 55 020 A000010 SANFORD C. BERNSTEIN & CO. LLC 020 B000010 13-2625874 020 C000010 46 021 000000 1379 022 A000001 J.P. MORGAN SECURITIES LLC 022 B000001 13-3224016 022 C000001 1784 022 D000001 0 022 A000002 UBS SECURITIES LLC 022 B000002 98-0186363 022 C000002 1784 022 D000002 0 023 C000000 3568 023 D000000 0 024 00AA00 Y 025 A00AA01 JP Morgan Chase 025 B00AA01 13-3224016 PAGE 3 025 C00AA01 E 025 D00AA01 51621 025 A00AA02 Wells Fargo 025 B00AA02 22-1147033 025 C00AA02 E 025 D00AA02 68243 026 A000000 N 026 B000000 Y 026 C000000 N 026 D000000 Y 026 E000000 N 026 F000000 N 026 G010000 N 026 G020000 N 026 H000000 N 027 000000 Y 028 A010500 28003 028 A020500 0 028 A030500 0 028 A040500 46334 028 B010500 27839 028 B020500 0 028 B030500 0 028 B040500 43226 028 C010500 33097 028 C020500 0 028 C030500 0 028 C040500 48983 028 D010500 55600 028 D020500 0 028 D030500 0 028 D040500 73921 028 E010500 27235 028 E020500 0 028 E030500 0 028 E040500 40688 028 F010500 50122 028 F020500 0 028 F030500 0 028 F040500 43748 028 G010500 221896 028 G020500 0 028 G030500 0 028 G040500 296900 028 H000500 39062 029 000500 Y 030 A000500 611 030 B000500 5.75 030 C000500 0.00 031 A000500 196 031 B000500 0 PAGE 4 032 000500 415 033 000500 0 034 000500 Y 035 000500 95 036 A000500 N 036 B000500 0 037 000500 N 038 000500 0 039 000500 N 040 000500 Y 041 000500 Y 042 A000500 0 042 B000500 0 042 C000500 0 042 D000500 0 042 E000500 0 042 F000500 0 042 G000500 0 042 H000500 0 043 000500 4514 044 000500 6510 045 000500 Y 046 000500 N 047 000500 Y 048 000500 0.000 048 A010500 300000 048 A020500 0.625 048 B010500 100000 048 B020500 0.500 048 C010500 0 048 C020500 0.000 048 D010500 0 048 D020500 0.000 048 E010500 0 048 E020500 0.000 048 F010500 0 048 F020500 0.000 048 G010500 0 048 G020500 0.000 048 H010500 0 048 H020500 0.000 048 I010500 0 048 I020500 0.000 048 J010500 0 048 J020500 0.000 048 K010500 400000 048 K020500 0.450 049 000500 N 050 000500 N 051 000500 N 052 000500 N PAGE 5 053 A000500 Y 053 B000500 Y 053 C000500 N 054 A00AA00 Y 054 B00AA00 Y 054 C00AA00 Y 054 D00AA00 N 054 E00AA00 N 054 F00AA00 N 054 G00AA00 Y 054 H00AA00 Y 054 I00AA00 N 054 J00AA00 Y 054 K00AA00 N 054 L00AA00 Y 054 M00AA00 Y 054 N00AA00 N 054 O00AA00 Y 055 A000500 N 055 B000500 N 056 000500 Y 057 000500 N 058 A00AA00 N 059 00AA00 Y 060 A00AA00 Y 060 B00AA00 Y 061 00AA00 1000 062 A000500 N 062 B000500 0.0 062 C000500 0.0 062 D000500 0.0 062 E000500 0.0 062 F000500 0.0 062 G000500 0.0 062 H000500 0.0 062 I000500 0.0 062 J000500 0.0 062 K000500 0.0 062 L000500 0.0 062 M000500 0.0 062 N000500 0.0 062 O000500 0.0 062 P000500 0.0 062 Q000500 0.0 062 R000500 0.0 063 A000500 0 063 B000500 0.0 066 A000500 Y 066 B000500 N 066 C000500 N 066 D000500 Y PAGE 6 066 E000500 N 066 F000500 N 066 G000500 N 067 000500 N 068 A000500 N 068 B000500 N 069 000500 N 070 A010500 Y 070 A020500 N 070 B010500 Y 070 B020500 Y 070 C010500 Y 070 C020500 N 070 D010500 Y 070 D020500 Y 070 E010500 Y 070 E020500 N 070 F010500 Y 070 F020500 N 070 G010500 Y 070 G020500 N 070 H010500 Y 070 H020500 N 070 I010500 Y 070 I020500 N 070 J010500 Y 070 J020500 N 070 K010500 Y 070 K020500 Y 070 L010500 Y 070 L020500 Y 070 M010500 Y 070 M020500 Y 070 N010500 Y 070 N020500 N 070 O010500 Y 070 O020500 N 070 P010500 Y 070 P020500 Y 070 Q010500 N 070 Q020500 N 070 R010500 Y 070 R020500 N 071 A000500 2209429 071 B000500 2424221 071 C000500 2426389 071 D000500 91 072 A000500 12 072 B000500 2 072 C000500 47612 072 D000500 0 PAGE 7 072 E000500 26 072 F000500 11916 072 G000500 2 072 H000500 0 072 I000500 4210 072 J000500 15 072 K000500 0 072 L000500 0 072 M000500 50 072 N000500 14 072 O000500 0 072 P000500 0 072 Q000500 15 072 R000500 21 072 S000500 19 072 T000500 4474 072 U000500 0 072 V000500 0 072 W000500 467 072 X000500 21203 072 Y000500 103 072 Z000500 26540 072AA000500 325098 072BB000500 0 072CC010500 0 072CC020500 262926 072DD010500 5662 072DD020500 0 072EE000500 0 073 A010500 0.1529 073 A020500 0.0000 073 B000500 0.0000 073 C000500 0.0000 074 A000500 770 074 B000500 0 074 C000500 0 074 D000500 0 074 E000500 0 074 F000500 2351347 074 G000500 0 074 H000500 0 074 I000500 5987 074 J000500 7067 074 K000500 0 074 L000500 1210 074 M000500 150 074 N000500 2366531 074 O000500 10052 074 P000500 867 074 Q000500 0 074 R010500 0 PAGE 8 074 R020500 0 074 R030500 0 074 R040500 3239 074 S000500 0 074 T000500 2352373 074 U010500 32892 074 U020500 1736 074 V010500 20.97 074 V020500 20.41 074 W000500 0.0000 074 X000500 189532 074 Y000500 55739 075 A000500 2520069 075 B000500 0 076 000500 0.00 077 A000000 Y 077 B000000 Y 077 C000000 N 077 D000000 N 077 E000000 Y 077 F000000 N 077 G000000 N 077 H000000 N 077 I000000 N 077 J000000 N 077 K000000 N 077 L000000 N 077 M000000 N 077 N000000 N 077 O000000 N 077 P000000 N 077 Q010000 N 077 Q020000 N 077 Q030000 N 078 000000 N 080 A00AA00 ICI Mutual Insurance Co. 080 C00AA00 130000 081 A00AA00 Y 081 B00AA00 118 082 A00AA00 N 082 B00AA00 0 083 A00AA00 N 083 B00AA00 0 084 A00AA00 N 084 B00AA00 0 085 A00AA00 Y 085 B00AA00 N 086 A010000 0 086 A020000 0 086 B010000 0 086 B020000 0 PAGE 9 086 C010000 0 086 C020000 0 086 D010000 0 086 D020000 0 086 E010000 0 086 E020000 0 086 F010000 0 086 F020000 0 SIGNATURE BRIAN W. WIXTED TITLE TREASURER EX-23 2 form_ex23-375.htm OPPENHEIMER VALUE FUND form_ex23-375.htm

Report of Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of

Oppenheimer Series Fund, Inc.:

In planning and performing our audit of the financial statements of Oppenheimer Value Fund (a portfolio of Oppenheimer Series Fund, Inc.) (the Fund) as of and for the year ended October 31, 2011, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-SAR, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion.

Management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of October 31, 2011.

This report is intended solely for the information and use of management and the Board of Directors of Oppenheimer Series Fund, Inc. and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties.

KPMG LLP

Denver, Colorado

December 16, 2011

EX-99.77E LEGAL 3 form_ex77e-375.htm OPPENHEIMER VALUE FUND form_ex77e-375.htm

N-SAR EXHIBIT 77E

Pending Litigation. Since 2009, a number of class action, derivative and individual lawsuits have been pending in federal and state courts against OppenheimerFunds, Inc., the Fund’s investment advisor (the “Manager”), OppenheimerFunds Distributor, Inc., the Fund’s principal underwriter and distributor (the “Distributor”), and certain funds (but not including the Fund) advised by the Manager and distributed by the Distributor (the “Defendant Funds”). Several of these lawsuits also name as defendants certain officers and current and former trustees of the respective Defendant Funds. The lawsuits raise claims under federal securities laws and various states’ securities, consumer protection and common law and allege, among other things, that the disclosure documents of the respective Defendant Funds contained misrepresentations and omissions and that the respective Defendant Funds’ investment policies were not followed. The plaintiffs in these actions seek unspecified damages, equitable relief and awards of attorneys’ fees and litigation expenses. On June 1, 2011, the U.S. District Court for the District of Colorado gave preliminary approval to stipulations and agreements of settlement in certain putative class action lawsuits involving two Defendant Funds, Oppenheimer Champion Income Fund and Oppenheimer Core Bond Fund. On September 30, 2011, the court entered orders and final judgments approving the settlements as fair, reasonable and adequate. Those orders are not subject to further appeal. These settlements do not resolve other outstanding lawsuits relating to Oppenheimer Champion Income Fund and Oppenheimer Core Bond Fund, nor do the settlements affect certain other putative class action lawsuits pending in federal court against the Manager, the Distributor, and other Defendant Funds and their independent trustees.

In 2009, what are claimed to be derivative lawsuits were filed in New Mexico state court against the Manager and a subsidiary (but not against the Fund) on behalf of the New Mexico Education Plan Trust challenging a settlement reached in 2010 between the Manager, its subsidiary and the Distributor and the board of the New Mexico section 529 college savings plan. These lawsuits allege breach of contract, breach of fiduciary duty, negligence and violation of state securities laws, and seek compensatory damages, equitable relief and an award of attorneys’ fees and litigation expenses. On September 9, 2011, the court denied plaintiffs’ request for a hearing to determine the fairness of the settlement, finding that plaintiffs lacked standing to pursue derivative claims on behalf of the Trust. On October 27, 2011, the parties to these actions filed a joint motion to dismiss the lawsuits with prejudice, which the court granted on October 28, 2011.

Other class action and individual lawsuits have been filed since 2008 in various state and federal courts against the Manager and certain of its affiliates by investors seeking to recover investments they allegedly lost as a result of the “Ponzi” scheme run by Bernard L. Madoff and his firm, Bernard L. Madoff Investment Securities, LLC (“BLMIS”). Plaintiffs in these suits allege that they suffered losses as a result of their investments in several funds managed by an affiliate of the Manager and assert a variety of claims, including breach of fiduciary duty, fraud, negligent misrepresentation, unjust enrichment, and violation of federal and state securities laws and regulations, among others. They seek unspecified damages, equitable relief and awards of attorneys’ fees and litigation expenses. Neither the Distributor, nor any of the Oppenheimer mutual funds, their independent trustees or directors are named as defendants in these lawsuits. None of the Oppenheimer mutual funds invested in any funds or accounts managed by Madoff or BLMIS. On February 28, 2011, a stipulation of partial settlement of three groups of consolidated putative class action lawsuits relating to these matters was filed in the U.S. District Court for the Southern District of New York. On August 19, 2011, the court entered an order and final judgment approving the settlement as fair, reasonable and adequate. In September 2011, certain parties filed notices of appeal from the court’s order approving the settlement. On July 29, 2011, a stipulation of settlement between certain affiliates of the Manager and the Trustee appointed under the Securities Investor Protection Act to liquidate BLMIS was filed in the U.S. Bankruptcy Court for the Southern District of New York to resolve purported preference and fraudulent transfer claims by the Trustee. On September 22, 2011, the court entered an order approving the settlement as fair, reasonable and adequate. In October 2011, certain parties filed notices of appeal from the court’s order approving the settlement. The aforementioned settlements do not resolve other outstanding lawsuits against the Manager and its affiliates relating to BLMIS.

On April 16, 2010, a lawsuit was filed in New York state court against the Manager, an affiliate of the Manager and AAArdvark IV Funding Limited (“AAArdvark IV”), an entity advised by the Manager’s affiliate, in connection with investments made by the plaintiffs in AAArdvark IV. Plaintiffs allege breach of contract against the defendants and seek compensatory damages, costs and disbursements, including attorney fees. On July 15, 2011, a lawsuit was filed in New York state court against the Manager, an affiliate of the Manager and AAArdvark Funding Limited (“AAArdvark I”), an entity advised by the Manager’s affiliate, in connection with investments made by the plaintiffs in AAArdvark I. The complaint alleges breach of contract against the defendants and seeks compensatory damages, costs and disbursements, including attorney fees. On November 9, 2011, a lawsuit was filed in New York state court against the Manager, an affiliate of the Manager and AAArdvark XS Funding Limited (“AAArdvark XS”), an entity advised by the Manager’s affiliate, in connection with investments made by the plaintiffs in AAArdvark XS. The complaint alleges breach of contract against the defendants and seeks compensatory damages, costs and disbursements, including attorney fees.

The Manager believes the lawsuits and appeals described above are without legal merit and, with the exception of actions it has settled, is defending against them vigorously. The Defendant Funds’ Boards of Trustees have also engaged counsel to represent the Funds and the present and former Independent Trustees named in those suits. While it is premature to render any opinion as to the outcome in these lawsuits, or whether any costs that the Defendant Funds may bear in defending the suits might not be reimbursed by insurance, the Manager believes that these suits should not impair the ability of the Manager or the Distributor to perform their respective duties to the Fund, and that the outcome of all of the suits together should not have any material effect on the operations of any of the Oppenheimer mutual funds.

EX-99 4 form_ex99a-375.htm OPPENHEIMER VALUE FUND form_ex99a-375.htm

Net investment income (loss) and net realized gain (loss) may differ for financial

statement and tax purposes. The character of dividends and distributions made during

the fiscal year from net investment income or net realized gains may differ from their

ultimate characterization for federal income tax purposes. Also, due to timing of

dividends and distributions, the fiscal year in which amounts are distributed may differ

from the fiscal year in which the income or net realized gain was recorded by the Fund.

Accordingly, the following amounts have been reclassified for October 31, 2011. Net assets of

the Fund were unaffected by the reclassifications.

Increase to Increase to

Accumulated Accumulated

Net Investment Net Realized Loss

Income on Investments

------------------------------------------------------------------------------------------------------------

$2,067,227 $2,067,227